EE03806B1 - Lamivudiini ja sidovudiini sisaldavad farmatseutilised kompositsioonid - Google Patents

Lamivudiini ja sidovudiini sisaldavad farmatseutilised kompositsioonid

Info

Publication number
EE03806B1
EE03806B1 EEP199900175A EE9900175A EE03806B1 EE 03806 B1 EE03806 B1 EE 03806B1 EE P199900175 A EEP199900175 A EE P199900175A EE 9900175 A EE9900175 A EE 9900175A EE 03806 B1 EE03806 B1 EE 03806B1
Authority
EE
Estonia
Prior art keywords
zidovudine
pharmaceutical compositions
compositions containing
containing lamivudine
lamivudine
Prior art date
Application number
EEP199900175A
Other languages
English (en)
Estonian (et)
Other versions
EE9900175A (et
Inventor
Wayne Goodson Gary
Wayne Wood Allen
Jeannette Ford Katherine
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of EE9900175A publication Critical patent/EE9900175A/xx
Publication of EE03806B1 publication Critical patent/EE03806B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
EEP199900175A 1996-10-31 1997-10-29 Lamivudiini ja sidovudiini sisaldavad farmatseutilised kompositsioonid EE03806B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9622681.6A GB9622681D0 (en) 1996-10-31 1996-10-31 Pharmaceutical compositions
PCT/EP1997/005953 WO1998018477A2 (fr) 1996-10-31 1997-10-29 Compositions pharmaceutiques contenant de la lamivudine et de la zidovudine

Publications (2)

Publication Number Publication Date
EE9900175A EE9900175A (et) 1999-12-15
EE03806B1 true EE03806B1 (et) 2002-08-15

Family

ID=10802224

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900175A EE03806B1 (et) 1996-10-31 1997-10-29 Lamivudiini ja sidovudiini sisaldavad farmatseutilised kompositsioonid

Country Status (44)

Country Link
EP (1) EP0941100B1 (fr)
JP (1) JP2001502718A (fr)
KR (1) KR100551652B1 (fr)
AP (1) AP1067A (fr)
AR (1) AR009135A1 (fr)
AT (1) ATE241364T1 (fr)
AU (1) AU736607B2 (fr)
BG (1) BG64541B1 (fr)
BR (1) BR9712614A (fr)
CA (1) CA2270174A1 (fr)
CO (1) CO4930269A1 (fr)
CY (1) CY2485B1 (fr)
CZ (1) CZ296080B6 (fr)
DE (1) DE69722433T2 (fr)
DK (1) DK0941100T3 (fr)
EA (1) EA002437B1 (fr)
EE (1) EE03806B1 (fr)
ES (1) ES2200204T3 (fr)
GB (1) GB9622681D0 (fr)
GE (1) GEP20022735B (fr)
GT (1) GT199700116A (fr)
HK (1) HK1020880A1 (fr)
HR (1) HRP970569B1 (fr)
HU (1) HU224969B1 (fr)
ID (1) ID18698A (fr)
IL (1) IL129422A0 (fr)
IS (1) IS5024A (fr)
MY (1) MY119513A (fr)
NO (1) NO317163B1 (fr)
NZ (1) NZ335153A (fr)
OA (1) OA11038A (fr)
PA (1) PA8441101A1 (fr)
PE (1) PE10099A1 (fr)
PL (1) PL190349B1 (fr)
PT (1) PT941100E (fr)
SI (1) SI0941100T1 (fr)
SK (1) SK284286B6 (fr)
SV (1) SV1997000090A (fr)
TR (1) TR199900950T2 (fr)
UA (1) UA64725C2 (fr)
UY (1) UY24766A1 (fr)
WO (1) WO1998018477A2 (fr)
YU (1) YU19999A (fr)
ZA (1) ZA979726B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9622681D0 (en) * 1996-10-31 1997-01-08 Glaxo Group Ltd Pharmaceutical compositions
GB9809213D0 (en) * 1998-04-29 1998-07-01 Glaxo Group Ltd Pharmaceutical compositions
US7074417B2 (en) * 2000-10-13 2006-07-11 Advancis Pharmaceutical Corporation Multiple-delayed release anti-viral product, use and formulation thereof
WO2003090762A1 (fr) * 2002-04-23 2003-11-06 Lupin Limited Compositions retard contenant de la zidovudine et de la lamivudine
CA2505130C (fr) * 2002-11-08 2009-10-06 Glaxo Group Limited Compositions pharmaceutiques
ATE398455T1 (de) 2003-01-14 2008-07-15 Gilead Sciences Inc Zusammensetzungen und verfahren zur antiviralen kombinationstherapie
AR045841A1 (es) * 2004-09-28 2005-11-16 Richmond Sa Com Ind Y Financie Una composicion farmaceutica solida que comprende al tiazolil metil ester del acido [5s-(5r*, 8r*, 10r*,11r*)] -10- hidroxi-2- metil-5-(1-metiletil)-1-[2-(1-metiletil)-4-tiazolil]-3,6-dioxo-8,11-bis(fenilmetil)-2,4,7,12- tetraazatridecan-13-oico y un procedimiento para prepararla.
US20130115237A1 (en) 2010-06-09 2013-05-09 Vaccine Technologies, Incorporated Therapeutic immunization in hiv infected subjects to augment antiretroviral treatment
AU2013229274A1 (en) 2012-03-05 2014-09-04 Cipla Limited Pharmaceutical antiretroviral combinations comprising lamivudine, festinavir and nevirapine
EP2958563A2 (fr) * 2013-02-20 2015-12-30 AbbVie Inc. Formes posologiques sous forme de comprimés

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950652A (en) * 1987-03-23 1990-08-21 Hem Research, Inc. dsRNAs for combination therapy in the treatment of viral diseases
DK0513917T4 (da) * 1991-05-16 2001-06-25 Glaxo Group Ltd Antivirale kombinationer indeholdende nukleosidanaloger
GB9110624D0 (en) * 1991-05-16 1991-07-03 Glaxo Group Ltd Combinations
GB9622681D0 (en) * 1996-10-31 1997-01-08 Glaxo Group Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
CA2270174A1 (fr) 1998-05-07
KR20000052893A (ko) 2000-08-25
SI0941100T1 (en) 2003-12-31
TR199900950T2 (xx) 1999-07-21
HU224969B1 (en) 2006-04-28
EP0941100B1 (fr) 2003-05-28
HUP0000344A3 (en) 2002-04-29
ID18698A (id) 1998-04-30
YU19999A (sh) 2000-10-30
JP2001502718A (ja) 2001-02-27
UY24766A1 (es) 2000-12-29
OA11038A (en) 2002-02-06
PT941100E (pt) 2003-10-31
HRP970569B1 (en) 2004-10-31
PL190349B1 (pl) 2005-11-30
CZ296080B6 (cs) 2006-01-11
MY119513A (en) 2005-06-30
ATE241364T1 (de) 2003-06-15
NZ335153A (en) 2001-04-27
HRP970569A2 (en) 1998-08-31
PE10099A1 (es) 1999-03-02
AR009135A1 (es) 2000-03-08
BG103435A (en) 2000-04-28
SK284286B6 (sk) 2005-01-03
CO4930269A1 (es) 2000-06-27
ZA979726B (en) 1999-04-29
WO1998018477A2 (fr) 1998-05-07
AU736607B2 (en) 2001-08-02
CZ155799A3 (cs) 1999-10-13
HUP0000344A2 (hu) 2001-05-28
SV1997000090A (es) 1998-10-07
IS5024A (is) 1999-04-09
WO1998018477A3 (fr) 1998-06-18
DE69722433D1 (de) 2003-07-03
DK0941100T3 (da) 2003-09-01
GEP20022735B (en) 2002-07-25
AU5314298A (en) 1998-05-22
BR9712614A (pt) 1999-10-26
CY2485B1 (en) 2005-06-03
PA8441101A1 (es) 2000-05-24
GB9622681D0 (en) 1997-01-08
KR100551652B1 (ko) 2006-02-13
AP1067A (en) 2002-05-01
UA64725C2 (uk) 2004-03-15
PL333143A1 (en) 1999-11-22
EA002437B1 (ru) 2002-04-25
EA199900345A1 (ru) 2000-02-28
HK1020880A1 (en) 2000-05-26
AP9901519A0 (en) 1999-06-30
NO317163B1 (no) 2004-08-30
GT199700116A (es) 1999-04-22
ES2200204T3 (es) 2004-03-01
IL129422A0 (en) 2000-02-17
EP0941100A2 (fr) 1999-09-15
DE69722433T2 (de) 2004-04-08
EE9900175A (et) 1999-12-15
BG64541B1 (bg) 2005-07-29
NO992091D0 (no) 1999-04-29
SK57599A3 (en) 2000-06-12
NO992091L (no) 1999-06-29

Similar Documents

Publication Publication Date Title
NO20002359L (no) Adenosinderivater og farmasoytisk sammensetning inneholdende derivatene
NO962606L (no) Farmasöytisk sammensetning
CY2005007I2 (el) Φαρμακευτικες συνθεσεις που περιεχουν δαριφενακινη
FI973475A (fi) Koostumus ja sitä sisältävä tuote
ID17774A (id) Komposisi farmasi antitrombosis
EE200000646A (et) Abakaviiri, lamivudiini ja zidovudiini sisaldavadhomogeensed farmatseutilised kompositsioonid
BR9509688A (pt) Composto e composição farmacêutica
EE9900175A (et) Lamivudiini ja sidovudiini sisaldavad farmatseutilised kompositsioonid
BR9507768A (pt) Composição farmacêutica
ID29294A (id) Komposisi farmasi
FI973229A0 (fi) Uusi farmaseuttinen koostumus
LV11727A (lv) Farmaceitiska kompozicija
ID25857A (id) Komposisi farmasi
FI973280A (fi) Farmaseuttinen koostumus
ITMI962628A0 (it) Composizione farmaceutica
BR9605777A (pt) Composição farmacêutica
ID23531A (id) Komposisi farmasi
IT1272935B (it) Composizione farmaceutica contenente n-acetil-cisteina
NO964309D0 (no) Farmasöytisk sammensetning
BR1100391A (pt) Composto e composição farmacêutica
FI955181A0 (fi) Trymoktonaania ja ATZ:ä sisältävät farmaseuttiset koostumuset
SE9604299D0 (sv) Pharmaceutical composition
SE9601854D0 (sv) Farmaceutisk komposition
ID17133A (id) Komposisi farmasi
BR1101151A (pt) Compostos e composição farmacêutica

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

MA4A Abandonment or withdrawal

Effective date: 20060815